Francesco Maria Fusco, Nadia Sangiovanni, Nunzia Papa, Nunzia Cuomo, Orsola Tambaro, Valentina Iodice, Vincenzo Bruner, Maria Aurora Carleo, Viviana Rizzo, Giulia Palmiero, Mariana Di Lorenzo, Micaela Spatarella, Rosaria Viglietti, Vincenzo Sangiovanni, Vincenzo Esposito
{"title":"Adherence to antiretroviral therapy thought package-refill among HIV+ persons at \"D. Cotugno\" hospital, Naples, Italy.","authors":"Francesco Maria Fusco, Nadia Sangiovanni, Nunzia Papa, Nunzia Cuomo, Orsola Tambaro, Valentina Iodice, Vincenzo Bruner, Maria Aurora Carleo, Viviana Rizzo, Giulia Palmiero, Mariana Di Lorenzo, Micaela Spatarella, Rosaria Viglietti, Vincenzo Sangiovanni, Vincenzo Esposito","doi":"10.53854/liim-3003-13","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A gold-standard for the measurement of adherence to antiretroviral therapy (ART) is lacking. Aim of this study is to verify the feasibility of a package-refill-based measurement of ART at \"D. Cotugno\" hospital, Naples, Italy, and the factors associated to adherence.</p><p><strong>Methods: </strong>In the period January 2018-August 2020, we calculated the package-refill as the ratio between ART-packages actually withdrawn, and the ART packages needed to regularly take ART. Adherence was associated, trough a univariate e multivariate logistic regression, to demographical, behavioural and clinical factors.</p><p><strong>Results: </strong>1140 HIV+ subjects were included. At univariate logistic regression inadequate package-refill-based adherence is associated with HIV-RNA higher than 50 copies/mmL (OR 3.77-IC95% 2.76-5.13) and with HIVRNA higher than 200 copies/mmL (OR 3.98-IC95% 2.69-5.90). Being not-Italian and Injective-drug-user are associated with low adherence, having HIV/AIDS for more than 8 years is associated with better adherence.</p><p><strong>Conclusions: </strong>Package-refill is a suitable method for measuring adherence and is associated with the condition of viral failure.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"30 3","pages":"440-445"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448314/pdf/1124-9390_30_3_2022_440-445.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infezioni in Medicina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53854/liim-3003-13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: A gold-standard for the measurement of adherence to antiretroviral therapy (ART) is lacking. Aim of this study is to verify the feasibility of a package-refill-based measurement of ART at "D. Cotugno" hospital, Naples, Italy, and the factors associated to adherence.
Methods: In the period January 2018-August 2020, we calculated the package-refill as the ratio between ART-packages actually withdrawn, and the ART packages needed to regularly take ART. Adherence was associated, trough a univariate e multivariate logistic regression, to demographical, behavioural and clinical factors.
Results: 1140 HIV+ subjects were included. At univariate logistic regression inadequate package-refill-based adherence is associated with HIV-RNA higher than 50 copies/mmL (OR 3.77-IC95% 2.76-5.13) and with HIVRNA higher than 200 copies/mmL (OR 3.98-IC95% 2.69-5.90). Being not-Italian and Injective-drug-user are associated with low adherence, having HIV/AIDS for more than 8 years is associated with better adherence.
Conclusions: Package-refill is a suitable method for measuring adherence and is associated with the condition of viral failure.
期刊介绍:
The Journal publishes original papers, in Italian or in English, on topics concerning aetiopathogenesis, prevention, epidemiology, diagnosis, clinical features and therapy of infections, whose acceptance is subject to the referee’s assessment. The Journal is of interest not only to infectious disease specialists, microbiologists and pharmacologists, but also to internal medicine specialists, paediatricians, pneumologists, and to surgeons as well. The Editorial Board includes experts in each of the above mentioned fields.